Register

SmallMolecules.com > Supplier: caymanchemical

Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

SQ 29,548 5 mg | ≥98%

Cayman Chemical

A selective TP receptor antagonist

More Information Supplier Page

SQ 29,548 1 mg | ≥98%

Cayman Chemical

A selective TP receptor antagonist

More Information Supplier Page

SQ 29,548 25 mg | ≥98%

Cayman Chemical

A selective TP receptor antagonist

More Information Supplier Page

Squalene 100 g | ≥95%

Cayman Chemical

A biosynthetic precursor to steroids

More Information Supplier Page

Squalene 50 g | ≥95%

Cayman Chemical

A biosynthetic precursor to steroids

More Information Supplier Page

SR 0987 25 mg | ≥98%

Cayman Chemical

An agonist of RORγt

More Information Supplier Page

SR 0987 10 mg | ≥98%

Cayman Chemical

An agonist of RORγt

More Information Supplier Page

SR 0987 5 mg | ≥98%

Cayman Chemical

An agonist of RORγt

More Information Supplier Page

SR 0987 1 mg | ≥98%

Cayman Chemical

An agonist of RORγt

More Information Supplier Page

SR 1001 25 mg | ≥98%

Cayman Chemical

An RORα and γ inverse agonist

More Information Supplier Page

SR 1001 10 mg | ≥98%

Cayman Chemical

An RORα and γ inverse agonist

More Information Supplier Page

SR 1001 5 mg | ≥98%

Cayman Chemical

An RORα and γ inverse agonist

More Information Supplier Page

SR 1001 1 mg | ≥98%

Cayman Chemical

An RORα and γ inverse agonist

More Information Supplier Page

SR 1078 10 mg | ≥98%

Cayman Chemical

A selective RORα/RORγ agonist

More Information Supplier Page

SR 1078 5 mg | ≥98%

Cayman Chemical

A selective RORα/RORγ agonist

More Information Supplier Page

SR 1078 1 mg | ≥98%

Cayman Chemical

A selective RORα/RORγ agonist

More Information Supplier Page

SR 11302 25 mg | ≥95%

Cayman Chemical

An inhibitor of retinoid-induced AP-1 signaling

More Information Supplier Page

SR 11302 10 mg | ≥95%

Cayman Chemical

An inhibitor of retinoid-induced AP-1 signaling

More Information Supplier Page

SR 11302 5 mg | ≥95%

Cayman Chemical

An inhibitor of retinoid-induced AP-1 signaling

More Information Supplier Page

SR 11302 1 mg | ≥95%

Cayman Chemical

An inhibitor of retinoid-induced AP-1 signaling

More Information Supplier Page

SR 12343 25 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12343 10 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12343 5 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12343 1 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12460 25 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12460 10 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12460 5 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 12460 1 mg | ≥98%

Cayman Chemical

An IKKβ NBD mimetic

More Information Supplier Page

SR 142948 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A neurotensin receptor antagonist

More Information Supplier Page

SR 142948 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A neurotensin receptor antagonist

More Information Supplier Page

SR 142948 (hydrochloride) 1 mg | ≥98%

Cayman Chemical

A neurotensin receptor antagonist

More Information Supplier Page

SR 144528 50 mg | ≥98%

Cayman Chemical

A CB2 receptor antagonist

More Information Supplier Page

SR 144528 25 mg | ≥98%

Cayman Chemical

A CB2 receptor antagonist

More Information Supplier Page

SR 144528 10 mg | ≥98%

Cayman Chemical

A CB2 receptor antagonist

More Information Supplier Page

SR 144528 5 mg | ≥98%

Cayman Chemical

A CB2 receptor antagonist

More Information Supplier Page

SR 144528-d3 1 mg | Purity Not Available

Cayman Chemical

An internal standard for the quantification of SR 144528

More Information Supplier Page

SR 144528-d3 500 µg | Purity Not Available

Cayman Chemical

An internal standard for the quantification of SR 144528

More Information Supplier Page

SR 1555 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

An inverse agonist of RORγ

More Information Supplier Page

SR 1555 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

An inverse agonist of RORγ

More Information Supplier Page

SR 1555 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

An inverse agonist of RORγ

More Information Supplier Page

SR 1555 (hydrochloride) 1 mg | ≥98%

Cayman Chemical

An inverse agonist of RORγ

More Information Supplier Page

SR 16584 10 mg | ≥95%

Cayman Chemical

Selective antagonist of α3β4 nicotinic acetylcholine receptors

More Information Supplier Page

SR 16584 5 mg | ≥95%

Cayman Chemical

Selective antagonist of α3β4 nicotinic acetylcholine receptors

More Information Supplier Page

SR 16584 1 mg | ≥95%

Cayman Chemical

Selective antagonist of α3β4 nicotinic acetylcholine receptors

More Information Supplier Page

SR 1664 25 mg | ≥98%

Cayman Chemical

An inhibitor of Cdk5-mediated PPARγ phosphorylation

More Information Supplier Page

SR 1664 10 mg | ≥98%

Cayman Chemical

An inhibitor of Cdk5-mediated PPARγ phosphorylation

More Information Supplier Page

SR 1664 5 mg | ≥98%

Cayman Chemical

An inhibitor of Cdk5-mediated PPARγ phosphorylation

More Information Supplier Page

SR 1664 1 mg | ≥98%

Cayman Chemical

An inhibitor of Cdk5-mediated PPARγ phosphorylation

More Information Supplier Page

SR 16832 25 mg | ≥98%

Cayman Chemical

A dual-site covalent antagonist of PPARγ

More Information Supplier Page

SR 16832 10 mg | ≥98%

Cayman Chemical

A dual-site covalent antagonist of PPARγ

More Information Supplier Page